Study about effect of agressive uric acid decrease treatment on left ventricular hypertrophy

Study about effect of agressive uric acid decrease treatment on left ventricular hypertrophy - study about UA and LVH

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014113

Enrollment

240

Registered

2014-06-01

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LeftVentricular Hypertrophy

Interventions

LVH patients are divided into 2 groups: agressive UA decrease treatment group and standard treatment group. Patients of agressive UA decrease treatment group will have UA decrease treatment Patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) LVH patients who are diagnosed by echocardiogram 2) Patients who ha have normal or high UA level 3) Older than 20 years old 4) Patients who consented to the study

Exclusion criteria

Exclusion criteria: 1) Patients who has cardiomyopathy or valvular disease 2) Patients who has coronary artery diasese 3) Paitents who has congenital heart disease 4) Patients who has severe hepatic or renal diasese 5) Patinets who is taking diuretics 6) Patients who is allergic to Febxiostat 7) Pregnant or mother who is providing breast milk 8) Patients who doctor in charge diagnosed to be inappropriate for the study

Design outcomes

Primary

Measure	Time frame
Left Ventricular Mass	—

Secondary

Measure	Time frame
Cardiovascular event	—

Countries

Japan

Contacts

Public ContactHirotsugu Mitsuhashi

St Luke's International Hospital Cardiovascular center

mitsuhashi3615@yahoo.co.jp03-3541-5151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026